270 related articles for article (PubMed ID: 20668671)
1. MicroRNA expression variability in human cervical tissues.
Pereira PM; Marques JP; Soares AR; Carreto L; Santos MA
PLoS One; 2010 Jul; 5(7):e11780. PubMed ID: 20668671
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm.
Cheung TH; Man KN; Yu MY; Yim SF; Siu NS; Lo KW; Doran G; Wong RR; Wang VW; Smith DI; Worley MJ; Berkowitz RS; Chung TK; Wong YF
Cell Cycle; 2012 Aug; 11(15):2876-84. PubMed ID: 22801550
[TBL] [Abstract][Full Text] [Related]
3. Aberrant microRNA expression in human cervical carcinomas.
Rao Q; Shen Q; Zhou H; Peng Y; Li J; Lin Z
Med Oncol; 2012 Jun; 29(2):1242-8. PubMed ID: 21264530
[TBL] [Abstract][Full Text] [Related]
4. Identification of autophagy-associated miRNA signature for the cervical squamous cell cancer and high-grade cervical intraepithelial lesions.
Bayramoglu Tepe N; Bozgeyik E; Bozdag Z; Balat O; Ozcan HC; Ugur MG
Reprod Biol; 2021 Sep; 21(3):100536. PubMed ID: 34298410
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated microRNAs involved in the progression of cervical neoplasm.
Zeng K; Zheng W; Mo X; Liu F; Li M; Liu Z; Zhang W; Hu X
Arch Gynecol Obstet; 2015 Oct; 292(4):905-13. PubMed ID: 25851497
[TBL] [Abstract][Full Text] [Related]
6. Altered MicroRNA expression in cervical carcinomas.
Lee JW; Choi CH; Choi JJ; Park YA; Kim SJ; Hwang SY; Kim WY; Kim TJ; Lee JH; Kim BG; Bae DS
Clin Cancer Res; 2008 May; 14(9):2535-42. PubMed ID: 18451214
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
8. Patterns of known and novel small RNAs in human cervical cancer.
Lui WO; Pourmand N; Patterson BK; Fire A
Cancer Res; 2007 Jul; 67(13):6031-43. PubMed ID: 17616659
[TBL] [Abstract][Full Text] [Related]
9. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
[TBL] [Abstract][Full Text] [Related]
10. Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
Nair VB; Manasa VG; Sinto MS; Jayasree K; James FV; Kannan S
Int J Gynecol Cancer; 2018 Mar; 28(3):553-562. PubMed ID: 29466255
[TBL] [Abstract][Full Text] [Related]
11. A systematic study on dysregulated microRNAs in cervical cancer development.
He Y; Lin J; Ding Y; Liu G; Luo Y; Huang M; Xu C; Kim TK; Etheridge A; Lin M; Kong D; Wang K
Int J Cancer; 2016 Mar; 138(6):1312-27. PubMed ID: 26032913
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-381 targets G protein-Coupled receptor 34 (GPR34) to regulate the growth, migration and invasion of human cervical cancer cells.
Tan Y; Wang H; Zhang C
Environ Toxicol Pharmacol; 2021 Jan; 81():103514. PubMed ID: 33086148
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the microRNA expression profile of cervical squamous cell carcinoma metastases.
Ding H; Wu YL; Wang YX; Zhu FF
Asian Pac J Cancer Prev; 2014; 15(4):1675-9. PubMed ID: 24641388
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: clinical impact of miR-363-3p.
Park H; Lee MJ; Jeong JY; Choi MC; Jung SG; Joo WD; Lee C; An HJ
Gynecol Oncol; 2014 Dec; 135(3):565-72. PubMed ID: 25230213
[TBL] [Abstract][Full Text] [Related]
15. Screening for characteristic microRNAs between pre-invasive and invasive stages of cervical cancer.
Zhu XL; Wen SY; Ai ZH; Wang J; Xu YL; Teng YC
Mol Med Rep; 2015 Jul; 12(1):55-62. PubMed ID: 25695263
[TBL] [Abstract][Full Text] [Related]
16. Identification of critical microRNA gene targets in cervical cancer using network properties.
Sharma G; Agarwal SM
Microrna; 2014; 3(1):37-44. PubMed ID: 25069511
[TBL] [Abstract][Full Text] [Related]
17. Distinct cervical microRNA profiles are present in women destined to have a preterm birth.
Elovitz MA; Brown AG; Anton L; Gilstrop M; Heiser L; Bastek J
Am J Obstet Gynecol; 2014 Mar; 210(3):221.e1-11. PubMed ID: 24565431
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation regulated microRNAs in human cervical cancer.
Varghese VK; Shukla V; Kabekkodu SP; Pandey D; Satyamoorthy K
Mol Carcinog; 2018 Mar; 57(3):370-382. PubMed ID: 29077234
[TBL] [Abstract][Full Text] [Related]
19. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of aberrantly expressed long non‑coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer.
Chen P; Zhang W; Chen Y; Zheng X; Yang D
Mol Med Rep; 2020 Jul; 22(1):405-415. PubMed ID: 32377727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
